Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00536601 · OUTCOME

Overall Survival, Presented as the Estimate at 10-yrs (Median Follow-up Time in Survivors)

High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors · Source last updated 2021-04-22

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
Proportion of participants
Interval / dispersion
95% Confidence Interval
Time frame
Patients are followed up to maximum of 12 years

What was measured

Assessed using the product-limit based Kaplan Meier method.

Groups in this outcome

Acute Leukemia

Patients diagnosed with and treated for acute myeloid leukemia or acute lymphoblastic leukemia

Hodgkin Lymphoma

Patients diagnosed with and treated for Hodgkin Lymphoma

Non-Hodgkin Lymphoma

Patients diagnosed with and treated for Non-Hodgkin Lymphoma

MM/Amyloid

Patients diagnosed with or treated for multiple myeloma or amyloidosis

Solid Tumors

Patients diagnosed with and treated for a solid tumor

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Acute Leukemia6
Hodgkin Lymphoma21
Non-Hodgkin Lymphoma71
MM/Amyloid65
Solid Tumors11

Reported measurements

Source class 1
Values in Proportion of participants · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Acute Leukemia33Not reported071Not reported
Hodgkin Lymphoma61Not reported4082Not reported
Non-Hodgkin Lymphoma45Not reported3357Not reported
MM/Amyloid39Not reported2751Not reported
Solid Tumors46Not reported1675Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0
        upper Limit
        71
        value
        33
      2. group Id
        OG001
        lower Limit
        40
        upper Limit
        82
        value
        61
      3. group Id
        OG002
        lower Limit
        33
        upper Limit
        57
        value
        45
      4. group Id
        OG003
        lower Limit
        27
        upper Limit
        51
        value
        39
      5. group Id
        OG004
        lower Limit
        16
        upper Limit
        75
        value
        46
denoms
  1. counts
    1. group Id
      OG000
      value
      6
    2. group Id
      OG001
      value
      21
    3. group Id
      OG002
      value
      71
    4. group Id
      OG003
      value
      65
    5. group Id
      OG004
      value
      11
    units
    Participants
description
Assessed using the product-limit based Kaplan Meier method.
dispersion Type
95% Confidence Interval
groups
  1. description
    Patients diagnosed with and treated for acute myeloid leukemia or acute lymphoblastic leukemia
    id
    OG000
    title
    Acute Leukemia
  2. description
    Patients diagnosed with and treated for Hodgkin Lymphoma
    id
    OG001
    title
    Hodgkin Lymphoma
  3. description
    Patients diagnosed with and treated for Non-Hodgkin Lymphoma
    id
    OG002
    title
    Non-Hodgkin Lymphoma
  4. description
    Patients diagnosed with or treated for multiple myeloma or amyloidosis
    id
    OG003
    title
    MM/Amyloid
  5. description
    Patients diagnosed with and treated for a solid tumor
    id
    OG004
    title
    Solid Tumors
param Type
NUMBER
reporting Status
POSTED
time Frame
Patients are followed up to maximum of 12 years
title
Overall Survival, Presented as the Estimate at 10-yrs (Median Follow-up Time in Survivors)
type
SECONDARY
unit Of Measure
Proportion of participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice